Paradoxical HDL-C reduction during rosiglitazone and fibrate treatment
Author:
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2007.02029.x/fullpdf
Reference17 articles.
1. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS;Turner;Br Med J,1998
2. Rosiglitazone monotherapy is effective in patients with Type 2 diabetes;Lebovitz;J Clin Endocrinol Metab,2001
3. Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records;Boyle;Clin Ther,2002
4. A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors;Chiquette;Arch Intern Med,2004
5. Paradoxical high-density lipoprotein reduction induced by fenofibrate and ciprofibrate;Collinson;Ann Clin Biochem,1996
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone;Molecular & Cellular Proteomics;2016-03
2. Use of fibrates in the metabolic syndrome: A review;World Journal of Diabetes;2016
3. Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome;World Journal of Diabetes;2015
4. Treatment of metabolic syndrome with ankaflavin, a secondary metabolite isolated from the edible fungus Monascus spp.;Applied Microbiology and Biotechnology;2014-04-13
5. Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial;Diabetes Care;2014-02-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3